Handa Pharmaceuticals Inc
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
472.74 M TWD
830.67 M TWD
145.48 M
About Handa Pharmaceuticals Inc
Sector
Industry
Website
Headquarters
Tainan
Founded
2014
IPO date
Dec 28, 2016
Identifiers
2
ISIN TW0006620008
Handa Pharmaceuticals, Inc. engages in the research, development, design, and sale of pharmaceutical business. It focuses on the development of niche drug. It offers 505(b)2 new drugs, high-tech generic drugs and other biotechnology services. The company was founded by Yu Ling Fang on May 8, 2014 and is headquartered in Tainan, Taiwan.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6620 is 77.5 TWD — it has decreased by −2.28% in the past 24 hours. Watch Handa Pharmaceuticals Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange Handa Pharmaceuticals Inc stocks are traded under the ticker 6620.
6620 stock has fallen by −7.20% compared to the previous week, the month change is a −7.65% fall, over the last year Handa Pharmaceuticals Inc has showed a 3.33% increase.
We've gathered analysts' opinions on Handa Pharmaceuticals Inc future price: according to them, 6620 price has a max estimate of 125.00 TWD and a min estimate of 125.00 TWD. Watch 6620 chart and read a more detailed Handa Pharmaceuticals Inc stock forecast: see what analysts think of Handa Pharmaceuticals Inc and suggest that you do with its stocks.
6620 reached its all-time high on Feb 24, 2023 with the price of 217.6 TWD, and its all-time low was 15.0 TWD and was reached on Mar 30, 2020. View more price dynamics on 6620 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6620 stock is 3.13% volatile and has beta coefficient of 1.63. Track Handa Pharmaceuticals Inc stock price on the chart and check out the list of the most volatile stocks — is Handa Pharmaceuticals Inc there?
Today Handa Pharmaceuticals Inc has the market capitalization of 13.33 B, it has increased by 0.47% over the last week.
Yes, you can track Handa Pharmaceuticals Inc financials in yearly and quarterly reports right on TradingView.
Handa Pharmaceuticals Inc is going to release the next earnings report on Feb 25, 2026. Keep track of upcoming events with our Earnings Calendar.
6620 net income for the last quarter is 209.46 M TWD, while the quarter before that showed 146.99 M TWD of net income which accounts for 42.49% change. Track more Handa Pharmaceuticals Inc financial stats to get the full picture.
Yes, 6620 dividends are paid annually. The last dividend per share was 1.51 TWD. As of today, Dividend Yield (TTM)% is 1.90%. Tracking Handa Pharmaceuticals Inc dividends might help you take more informed decisions.
Handa Pharmaceuticals Inc dividend yield was 2.01% in 2024, and payout ratio reached 44.78%. The year before the numbers were 0.54% and 18.48% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 6620 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Handa Pharmaceuticals Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Handa Pharmaceuticals Inc technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Handa Pharmaceuticals Inc stock shows the sell signal. See more of Handa Pharmaceuticals Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.